...
首页> 外文期刊>Indian journal of public health. >Economic evaluation of iodine deficiency disorder control program in Sikkim: A cost-benefit analysis
【24h】

Economic evaluation of iodine deficiency disorder control program in Sikkim: A cost-benefit analysis

机译:锡金碘缺乏病控制计划的经济评估:成本效益分析

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: Iodine deficiency disorders (IDDs) are the most common cause of preventable brain damage globally. The strategy of prevention and control of iodine deficiency is based on iodine supplementation. Edible salt iodization and iodized oil injections are the two most commonly used vehicles for iodine supplementation. The objective of the study was to conduct a cost-benefit analysis of the two programs of iodine supplementation, i.e., iodized salt program (ISP) and iodized oil program (IOP) against no preventive program (NPP) option. Materials and Methods: The study was conducted in 1990 in the state of Sikkim in India. The costs were calculated on the assumption of universal coverage of ISP and coverage of IOP among all children aged 0-14 years and women in the age group of 15-44 years. Direct and indirect cost of ISP and direct cost of IOP was computed based on the costs of year 1991. The discount rate taken was 10% and all the costs were converted to the year 2010 using wholesale price index (WPI) data. Consequences in terms of health effects, Social/emotional effects, and resource use were included. Results: The discounted cost of ISP and IOP was Rs. 59,225,964 and Rs. 46,145,491, respectively. In ISP, 64.1% of the total cost was required for salt iodization, 17.6% for monitoring, and 18.3% for communication. In IOP, 50.9% of the costs were required for iodized oil; rest was for syringes and needles, manpower expenses, travel, and communication. Total resource saving was Rs. 95,566,220 for ISP and Rs. 92,177,548 for IOP. Incremental benefit for ISP was Rs. 36,340,256 and Rs. 46,032,057 for IOP. The cost-benefit ratio for ISP was 1.61 and 2.00 for IOP. Conclusion: IOP has a higher cost-benefit ratio for prevention of IDDs than ISP in the state of Sikkim, India.
机译:背景:碘缺乏症(IDD)是全球可预防的脑损伤的最常见原因。预防和控制碘缺乏的策略是基于补充碘。食用盐加碘和加碘油注射液是两种最常用的碘补充剂。这项研究的目的是对两种补充碘的方案,即无预防方案(NPP)的碘盐方案(ISP)和碘化油方案(IOP)进行成本效益分析。材料和方法:该研究于1990年在印度锡金进行。成本是基于所有0-14岁儿童和15-44岁年龄段妇女的ISP普遍覆盖和IOP覆盖的假设计算的。 ISP的直接和间接成本以及IOP的直接成本是根据1991年的成本计算的。折现率为10%,所有成本均使用批发价格指数(WPI)数据转换为2010年。在健康影响,社会/情感影响和资源利用方面的后果也包括在内。结果:ISP和IOP的折扣成本为Rs。 59,225,964和卢比。 46,145,491。在ISP中,加碘盐需要64.1%的总成本,监视需要17.6%的费用,而通讯需要18.3%的费用。在IOP中,加碘油需要50.9%的费用;其余的用于注射器和针头,人工费用,差旅和通讯。总资源节省为卢比。 ISP和卢比为95,566,220。 IOP的92,177,548。 ISP的增量收益为Rs。 36,340,256和卢比。 IOP为46,032,057。 ISP的成本效益比为1.61,IOP的成本效益比为2.00。结论:在印度锡金,IOP预防IDD的成本效益比高于ISP。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号